Research on the Effect of Equity Incentives for Pharmaceutical Manufacturing Enterprises
Abstract
Since the 2005 shareholder reform, China has begun to review and improve its shareholder laws and regulations. It has created a more favorable institutional environment for its development. Currently, there is a growing trend toward separation between corporate governance and ownership. The separation of these two rights inevitably raises a number of intermediation problems. The pharmaceutical indus
医药制造企业股权激励效果研究-11339字.docx